A Phase I Clinical Trial to Assess Safety and Tolerability of Injectable Collagenase in Women with Symptomatic Uterine Fibroids is a research paper published in Reproductive Sciences (2021). On theSindex it has a DataRank of 0.656. It has been cited 17 times, with 14 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.434
From this paper's citation signal
Citation Network Contribution
0.222
From 11 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 14 citers.
Howard and Georgeanna Jones Foundation for Reproductive Medicine
Grant: NA
Advance Biofractures Corp
Grant: NA-clinical research
NCATS NIH HHS
Grant: UL1 TR001079
National Institutes of Health
Grant: 3UL1TR001079-02S1
Institute for Clinical and Translational Research
FWCI
1.52
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals